Delivery Order SPE2DB22D3301-SPE2DB25FX5WU

Award Date 11/21/24
Potential Completion Date 12/13/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,104.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY (COVID-19) vaccines for individuals 12 years and older, with a period of performance through February 10, 2025. The contract was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,862.24, is for the delivery of COMIRNATY COVID-19 vaccines for individuals aged 12 and up, with a completion date of December 9, 2024. The contract is a firm fixed price delivery order and was not set aside for any specific business category....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for COMIRNATY (COVID-19) vaccines for individuals aged 12 and up. The order, valued at $1,414.44, has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide pharmaceuticals and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,701.40, is for the delivery of COMIRNATY (COVID-19) vaccines for individuals 12 years and older, with a completion date of December 17, 2024. This appears to be a Firm Fixed Price Delivery Order contract, with no set-aside requirements indicated. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of COMIRNATY (COVID-19 vaccine) vials for individuals 12 years and older. The contract has a ceiling value of $4,570.50 and a completion date of January 26, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,483.44 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of COMIRNATY (COVID-19) vaccines for individuals aged 12 and above, with a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical...
This is a $6,045.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY (COVID-19) vaccines for individuals aged 12 and up, with a completion date of January 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a $40,620.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the COMIRNATY COVID-19 vaccine for individuals 12 years and older, with a delivery date of July 8, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a substantial $999,999,999.00 Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COMIRNATY (COVID-19) vaccines for individuals aged 12 and older. The contract has a potential value of $4,404.15 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COMIRNATY (COVID-19) vaccines for individuals 12 years and older. The contract has a ceiling value of $1,480.58 and runs through March 27, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization registered in the System for Award Management...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5WU
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,441.74, is for the delivery of COMIRNATY (COVID-19) vaccines for individuals 12 years and older, with a completion date of December 13, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/20/25, 9:36 AM